Harmony Biosciences Files Q1 2025 10-Q
Ticker: HRMY · Form: 10-Q · Filed: 2025-05-06T00:00:00.000Z
Sentiment: neutral
Topics: 10-Q, quarterly-report, pharmaceuticals
TL;DR
Harmony Biosciences Q1 2025 10-Q is in. Check financials.
AI Summary
Harmony Biosciences Holdings, Inc. filed its 10-Q for the period ending March 31, 2025. The company reported financial results and provided updates on its business operations. Key financial figures and operational details are included in the filing.
Why It Matters
This filing provides investors with the latest financial performance and operational status of Harmony Biosciences, crucial for understanding the company's trajectory and making informed investment decisions.
Risk Assessment
Risk Level: medium — As a pharmaceutical company, Harmony Biosciences faces inherent risks related to drug development, regulatory approvals, and market competition, which are detailed in its SEC filings.
Key Numbers
- 20250331 — Reporting Period End Date (Indicates the end of the fiscal quarter for which financial information is reported.)
- 20250506 — Filing Date (The date the 10-Q report was officially submitted to the SEC.)
Key Players & Entities
- Harmony Biosciences Holdings, Inc. (company) — Filer of the 10-Q
- 20250331 (date) — End of the reporting period
- 20250506 (date) — Filing date
- 0001802665 (company) — Central Index Key for Harmony Biosciences Holdings, Inc.
FAQ
What is the primary business of Harmony Biosciences Holdings, Inc.?
Harmony Biosciences Holdings, Inc. operates in the Pharmaceutical Preparations industry, as indicated by its Standard Industrial Classification code [2834].
What is the fiscal year end for Harmony Biosciences Holdings, Inc.?
The fiscal year end for Harmony Biosciences Holdings, Inc. is December 31 (1231).
What is the SEC file number for Harmony Biosciences Holdings, Inc.?
The SEC file number for Harmony Biosciences Holdings, Inc. is 001-39450.
What is the address of Harmony Biosciences Holdings, Inc.?
The business and mail address for Harmony Biosciences Holdings, Inc. is 630 W GERMANTOWN PIKE, SUITE 215, PLYMOUTH MEETING, PA 19462.
What is the accession number for this 10-Q filing?
The accession number for this 10-Q filing is 0001558370-25-006394.
From the Filing
0001558370-25-006394.txt : 20250506 0001558370-25-006394.hdr.sgml : 20250506 20250506081531 ACCESSION NUMBER: 0001558370-25-006394 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 91 CONFORMED PERIOD OF REPORT: 20250331 FILED AS OF DATE: 20250506 DATE AS OF CHANGE: 20250506 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Harmony Biosciences Holdings, Inc. CENTRAL INDEX KEY: 0001802665 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences EIN: 822279923 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-39450 FILM NUMBER: 25915363 BUSINESS ADDRESS: STREET 1: 630 W GERMANTOWN PIKE STREET 2: SUITE 215 CITY: PLYMOUTH MEETING STATE: PA ZIP: 19462 BUSINESS PHONE: (484) 539-9800 MAIL ADDRESS: STREET 1: 630 W GERMANTOWN PIKE STREET 2: SUITE 215 CITY: PLYMOUTH MEETING STATE: PA ZIP: 19462 10-Q 1 hrmy-20250331x10q.htm 10-Q HARMONY BIOSCIENCES HOLDINGS, INC._March 31, 2025 http://fasb.org/us-gaap/2024#ProductMember http://fasb.org/us-gaap/2024#ProductMember 0001802665 --12-31 Q1 false http://fasb.org/us-gaap/2024#OtherAssetsNoncurrent http://fasb.org/us-gaap/2024#OtherLiabilitiesCurrent http://fasb.org/us-gaap/2024#OtherLiabilitiesNoncurrent http://fasb.org/us-gaap/2024#RelatedPartyMember http://fasb.org/us-gaap/2024#RelatedPartyMember 0 0 http://fasb.org/us-gaap/2024#RelatedPartyMember http://fasb.org/us-gaap/2024#RelatedPartyMember http://fasb.org/us-gaap/2024#ProductMember http://fasb.org/us-gaap/2024#ProductMember http://fasb.org/us-gaap/2024#OtherAssetsNoncurrent http://fasb.org/us-gaap/2024#OtherLiabilitiesCurrent http://fasb.org/us-gaap/2024#OtherLiabilitiesNoncurrent 0001802665 hrmy:October2023ShareRepurchaseProgramMember 2025-03-31 0001802665 hrmy:October2023ShareRepurchaseProgramMember 2025-01-01 2025-03-31 0001802665 hrmy:October2023ShareRepurchaseProgramMember 2024-01-01 2024-03-31 0001802665 us-gaap:RetainedEarningsMember 2025-03-31 0001802665 us-gaap:AdditionalPaidInCapitalMember 2025-03-31 0001802665 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-03-31 0001802665 us-gaap:RetainedEarningsMember 2024-12-31 0001802665 us-gaap:AdditionalPaidInCapitalMember 2024-12-31 0001802665 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-12-31 0001802665 us-gaap:RetainedEarningsMember 2024-03-31 0001802665 us-gaap:AdditionalPaidInCapitalMember 2024-03-31 0001802665 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-03-31 0001802665 us-gaap:RetainedEarningsMember 2023-12-31 0001802665 us-gaap:AdditionalPaidInCapitalMember 2023-12-31 0001802665 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-12-31 0001802665 us-gaap:CommonStockMember 2025-03-31 0001802665 us-gaap:CommonStockMember 2024-12-31 0001802665 us-gaap:CommonStockMember 2024-03-31 0001802665 us-gaap:CommonStockMember 2023-12-31 0001802665 us-gaap:EmployeeStockOptionMember 2024-01-01 2024-03-31 0001802665 2023-12-31 2023-12-31 0001802665 srt:MinimumMember 2024-01-01 2024-12-31 0001802665 srt:MaximumMember 2024-01-01 2024-12-31 0001802665 us-gaap:RestrictedStockUnitsRSUMember 2024-12-31 0001802665 us-gaap:RestrictedStockUnitsRSUMember 2024-01-01 2024-03-31 0001802665 country:US hrmy:WAKIXMember 2022-02-01 2022-02-28 0001802665 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-01-01 2025-03-31 0001802665 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-01-01 2024-03-31 0001802665 us-gaap:RetainedEarningsMember 2025-01-01 2025-03-31 0001802665 us-gaap:RetainedEarningsMember 2024-01-01 2024-03-31 0001802665 srt:MinimumMember 2025-03-31 0001802665 srt:MaximumMember 2025-03-31 0001802665 us-gaap:RelatedPartyMember 2025-01-01 2025-03-31 0001802665 us-gaap:RelatedPartyMember 2024-01-01 2024-03-31 0001802665 hrmy:WAKIXMember 2022-03-31 0001802665 hrmy:CataplexyMember hrmy:NdaForWakixMember 2020-10-31 0001802665 hrmy:DaytimeSleepinessMember hrmy:WAKIXMember 2019-08-31 0001802665 hrmy:DaytimeSleepinessMember hrmy:WAKIXMember 2025-03